Warfarin
Showing 1 - 25 of 1,186
Left Ventricular Thrombus Trial in Peshawar (Warfarin, Rivaroxaban 20 MG Oral Tablet, Apixaban 5mg or 2.5mg oral tablet)
Recruiting
- Left Ventricular Thrombus
- Warfarin
- +2 more
-
Peshawar, KPK, PakistanPeshawar Institute of Cardiology
Jul 25, 2023
Drug Drug Interaction, Warfarin, Midazolam Trial in Guangzhou (ZSP1273)
Active, not recruiting
- Drug Drug Interaction
- +2 more
-
Guangzhou, Chinathe Second Affiliated Hospital of Guangzhou Medical University
Jul 4, 2023
Overweight Subjects, Obese Subjects Trial in Beijing (metformin, digoxin, IBI362)
Not yet recruiting
- Overweight Subjects
- Obese Subjects
- metformin
- +4 more
-
Beijing, Beijing, ChinaAerospace Center Hospital
Apr 4, 2023
Warfarin Trial in Hong Kong (Warfarin dosage adjustment model)
Recruiting
- Warfarin
- Warfarin dosage adjustment model
-
Hong Kong, Shatin, Hong KongPrince of Wales Hospital
Nov 2, 2022
Kawasaki Disease, Coronary Aneurysm, Rivaroxaban Trial (Rivaroxaban Oral Tablet or Suspension [Xarelto], Aspirin or Clopidogrel,
Not yet recruiting
- Kawasaki Disease
- +4 more
- Rivaroxaban Oral Tablet or Suspension [Xarelto]
- +2 more
- (no location specified)
Dec 6, 2022
Atrial Fibrillation, Peritoneal Dialysis Complication Trial (Anticoagulation Agents)
Not yet recruiting
- Atrial Fibrillation
- Peritoneal Dialysis Complication
- Anticoagulation Agents
- (no location specified)
Sep 13, 2023
Left Ventricular Thrombus, Myocardial Infarction Trial (Rivaroxaban, Warfarin)
Not yet recruiting
- Left Ventricular Thrombus
- Myocardial Infarction
- Rivaroxaban
- Warfarin
- (no location specified)
Mar 31, 2023
CTEPH Trial in Fukuoka (Edoxaban, Warfarin Potassium, Warfarin Potassium )
Active, not recruiting
- CTEPH
- Edoxaban
- +3 more
-
Fukuoka, JapanKyushu University Hospital
Aug 30, 2022
Left Ventricular Thrombus, ST Segment Elevation Myocardial Infarction Trial in Tehran (Rivaroxaban 15 MG, Warfarin)
Recruiting
- Left Ventricular Thrombus
- ST Segment Elevation Myocardial Infarction
- Rivaroxaban 15 MG
- Warfarin
-
Tehran, Iran, Islamic Republic of
- +1 more
Jan 21, 2023
Hemophilia A, Hemophilia B, Blood Coagulation Disorders Trial in Seoul (TU7710, Normal saline)
Recruiting
- Hemophilia A
- +2 more
- TU7710
- Normal saline
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 8, 2023
Atrial Fibrillation, Valvular Heart Disease Trial in Beijing (Gene-directed dosage of warfarin, standard dosage of warfarin)
Completed
- Atrial Fibrillation
- Valvular Heart Disease
- Gene-directed dosage of warfarin
- standard dosage of warfarin
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences Fuwai Hospital
Apr 28, 2022
Anticoagulation, Coronary Endarterectomy Trial (Warfarin, DAPT, CE+CABG)
Not yet recruiting
- Anticoagulation
- Coronary Endarterectomy
- Warfarin
- +2 more
- (no location specified)
Mar 26, 2023
Apixaban Compared to Warfarin in Non-valvular Atrial
Not yet recruiting
- Non-valvular Atrial Fibrillation
- (no location specified)
Jul 20, 2022
Kidney's Ability to Work Properly in Korean Non-valvular Atrial
Active, not recruiting
- Non-valvular Atrial Fibrillation (NVAF)
- Rivaroxaban (Xarelto, BAY59-7939)
- Warfarin
-
Multiple Locations, Korea, Republic ofMany locations
Aug 11, 2022
Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)
Recruiting
- Cirrhosis
- +3 more
- Apixaban
- +4 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College of Yangzhou University
Mar 19, 2022
Chronic Hepatitis B Trial (HRS5091 Tablets, Midazolam Maleate Tablets, Warfarin Sodium Tablets)
Completed
- Chronic Hepatitis B
- HRS5091 Tablets
- +6 more
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou Medical University
Dec 22, 2022
Clotting Disorder Trial (Reinforcement Learning, Heath Care Provider)
Withdrawn
- Clotting Disorder
- Reinforcement Learning
- Heath Care Provider
- (no location specified)
Feb 17, 2022
Quality of Life Trial in Edmonton (Patient Self-Management)
Completed
- Quality of Life
- Patient Self-Management
-
Edmonton, Alberta, CanadaUniversity of Alberta
May 24, 2022
Healthy Subjects Trial in Suzhou (Warfarin sodium tablets, Digoxin tablet, Probenecid tablets)
Completed
- Healthy Subjects
- Warfarin sodium tablets
- +3 more
-
Suzhou, ChinaFirst Affiliated Hospital of Soochow University
Mar 9, 2022
Atopic Dermatitis Trial (Caffeine, Metoprolol, Midazolam)
Not yet recruiting
- Atopic Dermatitis
- Caffeine
- +6 more
- (no location specified)
May 26, 2023